• 2 months 3 weeks ago Help us improve our website: http://t.co/vY9vRzmYRH! Please take our visitor survey: http://t.co/8gY0wRZtGx. Thank you...
  • 2 months 3 weeks ago 1st European Research Forum on Healthy Ageing: 03 Sept in Bxl. Policy makers, scientists, industrials: save the date! http://t.co/6TXrBI5rdt
  • 3 months 5 days ago Gender inequalities in health: a matter of policies according to @sophieproject http://t.co/TzwZzXko3g
  • 4 months 2 days ago 1/3 of cancer patients killed by 'fat-burning' process termed cachexia, @CNIO_Cancer researchers say http://t.co/GjfipsdG2R
  • 5 months 4 hours ago New EU research project @pneumonp aims to tackle antibiotic resistance via inhalable nano therapeutics #nanomedicine http://t.co/VQN9WHojG2
  • 5 months 2 weeks ago Urban renewal improves the health of neighbours in Barcelona according to EU-funded project @sophieproject http://t.co/F0mKCdPBZ5
  • 5 months 3 weeks ago Check this article on #CommHERE: how to spread the word about research and reach out beyond the scientific community http://t.co/VDcKVDEfcc
  • 6 months 2 weeks ago Scientists @CNIO_Cancer among the 40 most important global researchers http://t.co/Rc0hIsq6dN
  • 6 months 4 weeks ago 2nd workshop @CIBER_ISCIII to strengthen the EU‐LAC Health Research Cooperation http://t.co/93qLQObcQj
  • 8 months 2 weeks ago The European Symposium in Drug Synthesis @unisiena will take place on May 18-23. You can register until April 15!! http://t.co/V8kxQIev9S

SCR&Tox

portrait of Prof. Marc Peschanski, Scientific Coordinator of SCR&Tox

Prof. Marc Peschanski

Scientific Coordinator of SCR&Tox, based at the Institute for Stem cell Therapy and Exploration of Monogenic diseases (I-Stem) at Institut National de la Santé et de la Recherche Médicale (Inserm), France

Research field

Stem Cells, Toxicology

If you like this
If you want to know more
Research Profile

Who?

“My passion for stem cells began 30 years ago. These cells form the basis of the regenerative medicine of the future. The cells enable me to do what I dreamed of: to treat patients”, confesses Professor Marc Peschanski. Prof. Peschanski has been exploring the therapeutic application of embryonic stem cells for years now.

Why?

It is vital to identify toxic compounds at an early stage in their development. Human pluripotent stem cell lines can divide indefinitely and can be triggered to differentiate into any cell type. This makes them uniquely suited to develop a wide variety of human cell-based tests, providing an alternative to animal testing.

What?

SCR&Tox aims to develop methods to predict the toxicity of drugs and cosmetics in tissues derived from pluripotent stem cells. “We will measure if cellular pathways within tissues are altered by chronic exposure to these products, focussing on five organs: the liver, heart, skin, nervous system and musculoskeletal system.”

How?

SCR&Tox brings together 13 internationally renowned research teams and manufacturers from France, Germany, Italy, Sweden and the UK. Its members provide a wide range of expertise needed to develop biological and technological resources. SCR&Tox is closely associated with other European consortia to form the SEURAT-1 consortium.

Stem cells: an alternative to animal testing

In the Picture
In the Picture
SCR&Tox project website I-Stem TV YouTube channel Toxicity Testing in the 21st Century SEURAT-1 (the related projects) Institut National de la Santé et de la Recherche Médicale (Inserm) SyStemAge (a related project) PDF versionPDF version
Image credits

Background image: SCR&Tox

Portrait of the project coordinator: SCR&Tox

Timeline (in chronological order): 1950: Inserm / F. Koulikoff; 1958: Inserm / M. Depardieu; 1991: Inserm / M. Peschanski; 2012: Abhijit Bhaduri on Flickr Creative Commons